QTXB   $0.0075  7.14% Market Open

QuantRx Biomedical Corp
Last Events:

2023-03-29 Trend pattern changed from канал to расходящийся клин с наклоном вниз.

2023-03-29 Signal in Stochastic changed from bullish reversal to bearish. The stochastic indicator is in the lower part of the neutral territory and it falls. These factors indicate that negative dynamics persists. Last signal: down-crossing the middle level.

2023-03-29 Signal in MACD changed from bearish weakening to bullish weakening. Oscillator MACD is in the positive territory it's higher than the signal line and falls. These factors mean that the growing trend persists, but the growth rate is declining. Last signal: signal line crossed the middle level.

2023-03-29 Signal in RSI changed from bullish to bearish weakening. RSI indicator is in the lower part of the neutral territory and it heading north. These factors indicate that the upside trend is forming Last signal: exit from the overbought zone.

2023-03-29 Signal in EMA20 changed from bullish reversal to bearish reversal. 2023-02-09 the price crossed down the moving average line and trying to form a short-term downside trend.

2023-03-29 Trend Power changed from almost flat to slow.

2023-03-29 Trend changed from flat and down to turning down.

2023-03-29 Trend pattern changed from расходящийся клин с наклоном вниз to канал.


Current temperature: 0.00
ST: 0, Cor:

Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total - - -
rsi ActivelyBuy - -
macd - - -
stoch - - -
ma20 Buy Sell -
ma50 - - -
ma100 - - -
Candlestick PatternAug. 16, 2022 Doji - is formed when the open and the close are the same or very close. The body of candle is small. The length of the shadows are not important. The appearance of a Doji should alert the investor of major indecision.
ISIN US74765N1090
ceo Dr. Shalom Z. Hirschman M.D.
Website https://www.quantrx.com/index.htm
QuantRx Biomedical Corporation engages in the development and commercialization of patented miniform pads (PADs) and PAD based over-the-counter products in the United States. It is also developing genomic diagnostics for the laboratory market based on its lateral flow patents, including RapidSense technology, a one-step lateral flow test. The company's PAD products are used for the treatment of hemorrhoids, minor vaginal infection, urinary incontinence, general catamenial uses, and other medical needs. Its products include InSync, a feminine hygienic interlabial pad; Unique miniform, a treated pad for the temporary relief of the itch and discomfort associated with hemorrhoids and minor vaginal infection, as well as an untreated pad for the daily protection of light urinary, vaginal, or anal leakage; and other treated miniform products. QuantRx Biomedical Corporation was incorporated in 1986 and is based in Tualatin, Oregon.